#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thymic carcinoma Vitamin B12 deficiency Ventricular fibrillation Hyperadrenocorticism Transient ischaemic attack Arteriovenous malformation Primary myelofibrosis Oesophageal adenocarcinoma stage II Chronic hepatitis B Erythema Li-Fraumeni syndrome Cardiac sarcoidosis Human papilloma virus immunisation Dermatomyositis Waldenstrom's macroglobulinaemia refractory More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Basic Information Hereditary angioedema – Life with Disease Bronchiolitis obliterans syndrome – Life with Disease Gastrointestinal stromal tumour – Trials in Disease Ocular melanoma – Trials in Disease Lennox-Gastaut syndrome – Diagnostics Chordoma – Trials in Disease Mitochondrial myopathy – Basic Information Focal segmental glomerulosclerosis – Trials in Disease Combined immunodeficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IMB 101 Glutathione Fosfomycin Trometamol Raludotatug Deruxtecan Fingolimod Mycophenolate Sodium Metyrapone Bp Pamiparib Ethinylestradiol Valbenazine Ditosylate Glutenin HUMAN FIBROBLASTS Bi-1808 Thiamine Hydrochloride Prs-344 Dutasteride Tirzepatide Calcium Carbonate A/H1N1 INFLUENZA VACCINE CARBOMER 980 More therapies…

    Learn about Your Condition

    Constipation Rhabdoid tumour of the kidney Richter's syndrome Laparoscopic surgery Uveal melanoma Malignant melanoma of eyelid Major depression Kearns-Sayre syndrome Urinary tract infection Diverticulitis Lennox-Gastaut syndrome Neuroendocrine carcinoma Overweight Endometrial cancer metastatic Postoperative wound infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Intestifix for Treating Immune Activation in Patients with Liver Cirrhosis and Ascites

    Recruiting

    2 1
    Investigated Drugs:
    • Intestifix
    Germany

  • Study of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Folinate
    • Atezolizumab
    • Bevacizumab
    Italy

  • Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Levoleucovorin
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    France

  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    Austria Belgium France Italy The Netherlands Norway +3

  • Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Germany

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France
Previous Page
1 … 20 21 22 23 24 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!